APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ripretinib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ripretinib Industry Growth and Trends Forecast to 2032

2 January 202697 pages

Choose your research edition.

Industry ResearchRipretinib Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Ripretinib Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Ripretinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ripretinib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ripretinib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ripretinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ripretinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ripretinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ripretinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ripretinib include Zai Lab Pharmaceutical Co., Ltd., TargetMol, MedKoo Biosciences, MedChem Express and Deciphera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ripretinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ripretinib market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ripretinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ripretinib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ripretinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ripretinib Market by Company

Zai Lab Pharmaceutical Co., Ltd.

TargetMol

MedKoo Biosciences

MedChem Express

Deciphera

Ripretinib Segment by Type

Tablet

Capsule

Ripretinib Segment by Application

Gastric Stromal Tumor Treatment

Mastocytosis

Ripretinib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ripretinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ripretinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ripretinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ripretinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ripretinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Ripretinib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ripretinib Sales by Type (2021-2026) & (K Units) Table 5. Global Ripretinib Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ripretinib Sales Market Share in Value by Type (2021-2026) Table 8. Global Ripretinib Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ripretinib Sales by Type (2027-2032) & (K Units) Table 10. Global Ripretinib Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ripretinib Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ripretinib Sales Market Share in Value by Type (2027-2032) Table 13. Global Ripretinib Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ripretinib Sales by Type (2021-2026) & (K Units) Table 15. North America Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ripretinib Sales by Type (2021-2026) & (K Units) Table 17. Europe Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ripretinib Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ripretinib Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ripretinib Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ripretinib Sales by Type (2021-2026) & (US$ Million) Table 24. Ripretinib Industry Trends Table 25. Ripretinib Industry Drivers Table 26. Ripretinib Industry Opportunities and Challenges Table 27. Ripretinib Industry Restraints Table 28. Global Ripretinib Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ripretinib Revenue Market Share by Company (2021-2026) Table 30. Global Ripretinib Sales by Company (2021-2026) & (K Units) Table 31. Global Ripretinib Sales Share by Company (2021-2026) Table 32. Global Ripretinib Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ripretinib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ripretinib Major Company Production Sites and Headquarters Table 35. Global Ripretinib Company, Product Type & Application Table 36. Global Ripretinib Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ripretinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ripretinib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ripretinib Sales by Region (2021-2026) & (K Units) Table 41. Global Ripretinib Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ripretinib Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ripretinib Sales Market Share in Value by Region (2021-2026) Table 44. Global Ripretinib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ripretinib Sales by Region (2027-2032) & (K Units) Table 46. Global Ripretinib Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ripretinib Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ripretinib Sales Market Share in Value by Region (2027-2032) Table 49. Global Ripretinib Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ripretinib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ripretinib Sales by Application (2021-2026) & (K Units) Table 52. Global Ripretinib Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ripretinib Sales Market Share in Value by Application (2021-2026) Table 55. Global Ripretinib Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ripretinib Sales by Application (2027-2032) & (K Units) Table 57. Global Ripretinib Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ripretinib Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ripretinib Sales Market Share in Value by Application (2027-2032) Table 60. Global Ripretinib Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ripretinib Sales by Application (2021-2026) & (K Units) Table 62. North America Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ripretinib Sales by Application (2021-2026) & (K Units) Table 64. Europe Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ripretinib Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ripretinib Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ripretinib Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ripretinib Sales by Application (2021-2026) & (US$ Million) Table 71. Zai Lab Pharmaceutical Co., Ltd. Company Information Table 72. Zai Lab Pharmaceutical Co., Ltd. Business Overview Table 73. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product Portfolio Table 75. Zai Lab Pharmaceutical Co., Ltd. Recent Development Table 76. TargetMol Company Information Table 77. TargetMol Business Overview Table 78. TargetMol Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. TargetMol Ripretinib Product Portfolio Table 80. TargetMol Recent Development Table 81. MedKoo Biosciences Company Information Table 82. MedKoo Biosciences Business Overview Table 83. MedKoo Biosciences Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. MedKoo Biosciences Ripretinib Product Portfolio Table 85. MedKoo Biosciences Recent Development Table 86. MedChem Express Company Information Table 87. MedChem Express Business Overview Table 88. MedChem Express Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. MedChem Express Ripretinib Product Portfolio Table 90. MedChem Express Recent Development Table 91. Deciphera Company Information Table 92. Deciphera Business Overview Table 93. Deciphera Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Deciphera Ripretinib Product Portfolio Table 95. Deciphera Recent Development Table 96. North America Ripretinib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Ripretinib Sales by Country (2021-2026) & (K Units) Table 98. North America Ripretinib Sales Market Share by Country (2021-2026) Table 99. North America Ripretinib Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Ripretinib Sales Market Share Forecast by Country (2027-2032) Table 101. North America Ripretinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Ripretinib Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Ripretinib Market Share by Country (2021-2026) Table 104. North America Ripretinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Ripretinib Market Share Forecast by Country (2027-2032) Table 106. Europe Ripretinib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Ripretinib Sales by Country (2021-2026) & (K Units) Table 108. Europe Ripretinib Sales Market Share by Country (2021-2026) Table 109. Europe Ripretinib Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Ripretinib Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Ripretinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Ripretinib Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Ripretinib Market Share by Country (2021-2026) Table 114. Europe Ripretinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Ripretinib Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Ripretinib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Ripretinib Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Ripretinib Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Ripretinib Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Ripretinib Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Ripretinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Ripretinib Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Ripretinib Market Share by Country (2021-2026) Table 124. Asia-Pacific Ripretinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Ripretinib Market Share Forecast by Country (2027-2032) Table 126. Latin America Ripretinib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Ripretinib Sales by Country (2021-2026) & (K Units) Table 128. Latin America Ripretinib Sales Market Share by Country (2021-2026) Table 129. Latin America Ripretinib Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Ripretinib Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Ripretinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Ripretinib Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Ripretinib Market Share by Country (2021-2026) Table 134. Latin America Ripretinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Ripretinib Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Ripretinib Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Ripretinib Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Ripretinib Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Ripretinib Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Ripretinib Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Ripretinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Ripretinib Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Ripretinib Market Share by Country (2021-2026) Table 144. Middle East and Africa Ripretinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Ripretinib Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Ripretinib Distributors List Table 149. Ripretinib Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Ripretinib Image Figure 2. Global Ripretinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ripretinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Ripretinib Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ripretinib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ripretinib Market Share by Type 2025 VS 2032 Figure 11. North America Ripretinib Sales Market Share in Volume by Type in 2025 Figure 12. North America Ripretinib Sales Market Share in Value by Type in 2025 Figure 13. Europe Ripretinib Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ripretinib Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ripretinib Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ripretinib Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ripretinib Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ripretinib Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ripretinib Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ripretinib Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ripretinib Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Gastric Stromal Tumor Treatment Image Figure 24. Global Gastric Stromal Tumor Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 25. Mastocytosis Image Figure 26. Global Mastocytosis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Ripretinib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Ripretinib Market Share by Application 2025 VS 2032 Figure 29. North America Ripretinib Sales Market Share in Volume by Application in 2025 Figure 30. North America Ripretinib Sales Market Share in Value by Application in 2025 Figure 31. Europe Ripretinib Sales Market Share in Volume by Application in 2025 Figure 32. Europe Ripretinib Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Ripretinib Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Ripretinib Sales Market Share in Value by Application in 2025 Figure 35. Latin America Ripretinib Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Ripretinib Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Ripretinib Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Ripretinib Sales Market Share in Value by Application in 2025 Figure 39. North America Ripretinib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Ripretinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Ripretinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Ripretinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Ripretinib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Ripretinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ripretinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Ripretinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Ripretinib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Ripretinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ripretinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Ripretinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Ripretinib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Ripretinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ripretinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Ripretinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Ripretinib Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Ripretinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ripretinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Ripretinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Ripretinib Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Ripretinib Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Gastric Stromal Tumor Treatment
  • Mastocytosis
Companies covered
  • Zai Lab Pharmaceutical Co., Ltd.
  • TargetMol
  • MedKoo Biosciences
  • MedChem Express
  • Deciphera

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ripretinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ripretinib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ripretinib Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Ripretinib Market Size by Type
  9. 1.4.1 Global Ripretinib Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ripretinib Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ripretinib Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ripretinib Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ripretinib Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ripretinib Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ripretinib Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ripretinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ripretinib Industry Trends
  2. 2.2 Ripretinib Industry Drivers
  3. 2.3 Ripretinib Industry Opportunities and Challenges
  4. 2.4 Ripretinib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ripretinib Revenue (2021-2026)
  2. 3.2 Global Top Players by Ripretinib Sales (2021-2026)
  3. 3.3 Global Top Players by Ripretinib Price (2021-2026)
  4. 3.4 Global Ripretinib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ripretinib Major Company Production Sites & Headquarters
  6. 3.6 Global Ripretinib Company, Product Type & Application
  7. 3.7 Global Ripretinib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ripretinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ripretinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ripretinib Tier 1, Tier 2, and Tier 3
4 Ripretinib Regional Status and Outlook
  1. 4.1 Global Ripretinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ripretinib Historic Market Size by Region
  3. 4.2.1 Global Ripretinib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ripretinib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ripretinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ripretinib Forecasted Market Size by Region
  7. 4.3.1 Global Ripretinib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ripretinib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ripretinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ripretinib by Application
  1. 5.1 Ripretinib Market by Application
  2. 5.1.1 Gastric Stromal Tumor Treatment
  3. 5.1.2 Mastocytosis
  4. 5.2 Global Ripretinib Market Size by Application
  5. 5.2.1 Global Ripretinib Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ripretinib Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ripretinib Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ripretinib Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ripretinib Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ripretinib Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ripretinib Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ripretinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zai Lab Pharmaceutical Co., Ltd.
  2. 6.1.1 Zai Lab Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zai Lab Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product Portfolio
  6. 6.1.5 Zai Lab Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 TargetMol
  8. 6.2.1 TargetMol Company Information
  9. 6.2.2 TargetMol Business Overview
  10. 6.2.3 TargetMol Ripretinib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TargetMol Ripretinib Product Portfolio
  12. 6.2.5 TargetMol Recent Developments
  13. 6.3 MedKoo Biosciences
  14. 6.3.1 MedKoo Biosciences Company Information
  15. 6.3.2 MedKoo Biosciences Business Overview
  16. 6.3.3 MedKoo Biosciences Ripretinib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MedKoo Biosciences Ripretinib Product Portfolio
  18. 6.3.5 MedKoo Biosciences Recent Developments
  19. 6.4 MedChem Express
  20. 6.4.1 MedChem Express Company Information
  21. 6.4.2 MedChem Express Business Overview
  22. 6.4.3 MedChem Express Ripretinib Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MedChem Express Ripretinib Product Portfolio
  24. 6.4.5 MedChem Express Recent Developments
  25. 6.5 Deciphera
  26. 6.5.1 Deciphera Company Information
  27. 6.5.2 Deciphera Business Overview
  28. 6.5.3 Deciphera Ripretinib Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Deciphera Ripretinib Product Portfolio
  30. 6.5.5 Deciphera Recent Developments
7 North America by Country
  1. 7.1 North America Ripretinib Sales by Country
  2. 7.1.1 North America Ripretinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ripretinib Sales by Country (2021-2026)
  4. 7.1.3 North America Ripretinib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ripretinib Market Size by Country
  6. 7.2.1 North America Ripretinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ripretinib Market Size by Country (2021-2026)
  8. 7.2.3 North America Ripretinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ripretinib Sales by Country
  2. 8.1.1 Europe Ripretinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ripretinib Sales by Country (2021-2026)
  4. 8.1.3 Europe Ripretinib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ripretinib Market Size by Country
  6. 8.2.1 Europe Ripretinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ripretinib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ripretinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ripretinib Sales by Country
  2. 9.1.1 Asia-Pacific Ripretinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ripretinib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ripretinib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ripretinib Market Size by Country
  6. 9.2.1 Asia-Pacific Ripretinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ripretinib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ripretinib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ripretinib Sales by Country
  2. 10.1.1 South America Ripretinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ripretinib Sales by Country (2021-2026)
  4. 10.1.3 South America Ripretinib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ripretinib Market Size by Country
  6. 10.2.1 South America Ripretinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ripretinib Market Size by Country (2021-2026)
  8. 10.2.3 South America Ripretinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ripretinib Sales by Country
  2. 11.1.1 Middle East and Africa Ripretinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ripretinib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ripretinib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ripretinib Market Size by Country
  6. 11.2.1 Middle East and Africa Ripretinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ripretinib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ripretinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ripretinib Value Chain Analysis
  2. 12.1.1 Ripretinib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ripretinib Production Mode & Process
  7. 12.2 Ripretinib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ripretinib Distributors
  10. 12.2.3 Ripretinib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst